Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $1,004,526 (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 43.7%

Value ($000) $439,452 Shares 14,040,000 Est. Cost $24.39 Unrealized +24.2%

BIIB BIOGEN INC 18.2%

Value ($000) $183,159 Shares 643,000 Est. Cost $278.12 Unrealized +7.1%

IRWD IRONWOOD PHARMACEUTICALS INC 17.4%

Value ($000) $174,390 Shares 16,390,000 Est. Cost $11.52 Unrealized -6.7%

INVA INNOVIVA INC 9.2%

Value ($000) $92,636 Shares 7,277,000 Est. Cost $13.02 Unrealized -3.9%

GILD GILEAD SCIENCES INC 7.1%

Value ($000) $70,935 Shares 920,400 Est. Cost $55.33 Unrealized +31.2%

NBIX NEUROCRINE BIOSCIENCES INC 2.2%

Value ($000) $21,812 Shares 231,300 Est. Cost $97.71 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 0.9%

Value ($000) $8,662 Shares 2,632,900 Est. Cost $9.56 Unrealized —

— AMARIN CORP PLC 0.6%

Value ($000) $5,843 Shares 4,910,000 Est. Cost $3.92 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 0.5%

Value ($000) $5,456 Shares 775,000 Est. Cost $4.84 Unrealized +65.8%

— VOR BIOPHARMA INC 0.2%

Value ($000) $1,910 Shares 618,000 Est. Cost $43.10 Unrealized —

— REGULUS THERAPEUTICS INC 0.0%

Value ($000) $272 Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	14,040,000	$439,452	43.7%	$24.39	+24.2%	SHS	G01767105
BIIB	BIOGEN INC	643,000	$183,159	18.2%	$278.12	+7.1%	COM	09062X103
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$174,390	17.4%	$11.52	-6.7%	COM CL A	46333X108
INVA	INNOVIVA INC	7,277,000	$92,636	9.2%	$13.02	-3.9%	COM	45781M101
GILD	GILEAD SCIENCES INC	920,400	$70,935	7.1%	$55.33	+31.2%	COM	375558103
NBIX	NEUROCRINE BIOSCIENCES INC	231,300	$21,812	2.2%	$97.71	0.0%	COM	64125C109
—	MERSANA THERAPEUTICS INC	2,632,900	$8,662	0.9%	$9.56	—	COM	59045L106
—	AMARIN CORP PLC	4,910,000	$5,843	0.6%	$3.92	—	SPONS ADR NEW	023111206
BCRX	BIOCRYST PHARMACEUTICALS INC	775,000	$5,456	0.5%	$4.84	+65.8%	COM	09058V103
—	VOR BIOPHARMA INC	618,000	$1,910	0.2%	$43.10	—	COM	929033108
—	REGULUS THERAPEUTICS INC	185,183	$272	0.0%	$2.07	—	COM	75915K309